Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca to Use Eidogen-Sertanty s Informatics System

NEW YORK, Dec. 15 (GenomeWeb News) - AstraZeneca will use Eidogen-Sertanty's target informatics platform for its drug-discovery efforts, Eidogen-Sertanty said today.


Under the agreement, scientists at AstraZeneca R&D Boston will access the protein structure informatics system and the EVE Comparative Visualization software within their cancer and anti-infective therapeutic programs.


Financial terms were not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.